Skip to main content
Clinical Trials/KCT0009224
KCT0009224
Not yet recruiting
未知

A Pilot study for Mobile Application-based Exercise Intervention and Nutrition Intervention for Cancer Patients with low muscle mass during chemotherapyNickname: SCONE (sarcopenia intervention for oncology patients with nutrition and exercise)

Asan Medical Center0 sites30 target enrollmentTBD
ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Asan Medical Center
Enrollment
30
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Age 19 or older
  • 2\) Patients with histologically confirmed solid cancer
  • 3\) Planned or receiving palliative chemotherapy or neoadjuvant/adjuvant chemotherapy using two or more cytotoxic chemotherapy agents
  • 4\) ECOG performance status 0\-2
  • 5\) If a basal abdominal CT (contrast CT must include the portal phase) that can confirm sarcopenia was taken within 4 weeks of participating in the study.
  • 6\) Class I or class II sarcopenia with skeletal muscle index (\=skeletal muscle area / BMI) T\-score less than \-1\.0 measured by CT
  • 7\) Life expectancy of more than 3 months
  • 8\) Patients who can understand the research subject consent document and are willing to sign it

Exclusion Criteria

  • 1\) Cases where there is a high risk of injury or fall during exercise intervention, such as bone metastasis, peripheral neuropathy, brain metastasis, etc.
  • 2\) Cases where it is difficult to follow the exercise intervention of the mobile application due to cognitive decline, illiteracy, or severe hearing and vision impairment.
  • 3\) If you do not have a smartphone
  • 4\) Cases where protein intake is limited due to decreased renal function (eGFR \<50mL/min/1\.73m2\)
  • 5\) When the researcher determines that exercise and nutritional intervention are not best for the patient due to other clinical conditions.
  • 6\) Over 80 years old

Outcomes

Primary Outcomes

Not specified

Similar Trials